毕得医药股东舟山欣曦、宁波兰旦及其一致行动人拟减持不超2.86%股份

Core Viewpoint - Bid Pharma (688073.SH) announced that its shareholders Zhoushan Xinxie, Ningbo Landan, and their concerted action person Mr. Wu Bo plan to reduce their holdings in the company [1] Shareholder Reduction Plans - Zhoushan Xinxie intends to reduce its shareholding by no more than 908,800 shares through block trading, which accounts for no more than 1.00% of the company's total share capital [1] - Ningbo Landan also plans to reduce its shareholding by no more than 908,800 shares through block trading, representing no more than 1.00% of the company's total share capital [1] - Shareholder Wu Bo plans to reduce his shareholding by no more than 785,800 shares through centralized bidding, which is no more than 0.86% of the company's total share capital [1]